1 dr.Boenjamin Setiawan, Ph.D. Future of Industrial Biotechnology dr.Boenjamin Setiawan, Ph.D.,UCSF 1.Biotechnology consists of Traditional and Modern.
Sicurezza e segnalazione degli eventi avversi: antibiotici, antinfiammatori, antidolorifici, stati febbrili. Effetto Nocebo del farmaco Achille P. Caputi.
Preparing an IND Application: CMC
Presentation istanbul
Biological Licensing Application - Evarrest
Physiological factors of drug absorption
Covance Biosimilars: Nonclinical & Clinical Development Challenges & Considerations
BIOTECHNOLOGY IN NEPAL A SYNOPSIS Professor Dr. Sarbajna Man Tuladhar Research Centre for Applied Science and Technology (RECAST) Tribhuvan University,
Biosimilars in Canada: A Perspective from Innovative Industry Karen A. Burke, Ph.D. Director, Regulatory Affairs and Safety Amgen Canada Montreal Forum.
Clinical Trials of Medicines in Ukraine Public Enterprise “The State Expert Center of the Ministry of Health of Ukraine” Valentina Nikolaieva PhD, Director.
Adding Safety Pharm Endopoints To General Tox Studies - II Michael J Engwall, DVM, PhD Principal Scientist Safety and Exploratory Pharmacology Toxicology.
